Development of an innovative 3D cell culture system to study tumour - Stroma interactions in non-small cell lung cancer cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Amann, Arno ^a   Zwierzina, Marit ^a   Gamerith, Gabriele ^a   Bitsche, Mario ^a   Huber, Julia M ^a   Vogel, Georg F ^a   Blumer, Michael ^a   Koeck, Stefan ^a   Pechriggl, Elisabeth J ^a   Kelm, Jens M ^b   Hilbe, Wolfgang ^a   Zwierzina, Heinz ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b InSphero AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 7; FIBRONECTIN; MONOCLONAL ANTIBODY KI 67; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CULTURE TECHNIQUE; EPITHELIAL MESENCHYMAL TRANSITION; LUNG CANCER CELL LINE; LUNG FIBROBLAST; LUNG NON SMALL CELL CANCER; PROTEIN EXPRESSION; THREE DIMENSIONAL CELL CULTURE; TISSUE INTERACTION; TUMOR STROMA INTERACTION; UPREGULATION; CELL COMMUNICATION; CYTOLOGY; DRUG DEVELOPMENT; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROCEDURES; STROMA CELL; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DRUG DISCOVERY; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; STROMAL CELLS;

EID: 84899752915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092511     Document Type: Article

References (33)

1. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380. doi:10.1056/NEJMra0802714.
2. Dacic S (2011) Molecular diagnostics of lung carcinomas. Arch Pathol Lab Med 135: 622-629. doi:10.1043/2010-0625-RAIR.1.
3. Pearson R, Kolesar JM (2011) Targeted therapy for NSCLC: ALK inhibition. Journal of Oncology Pharmacy Practice 18: 271-274. doi:10.1177/1078155211417477.
4. Forde PM, Rudin CM (2012) Crizotinib in the treatment of non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 13: 1195-1201. doi:10.1517/14656566.2012.688029.
5. Kotsakis A, Georgoulias V (2010) Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 11: 2363-2389. doi:10.1517/14656566.2010.498581.
6. Subramanian J, Madadi AR, Dandona M, Williams K, Morgensztern D, et al. (2010) Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website. J Thorac Oncol 5: 1116-1119. doi:10.1097/JTO.0b013e3181e76159.
7. Arteaga CL (2003) Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer. Breast Cancer Res 5: 96-100.
8. Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445: 851-857. doi:10.1038/nature05661.
9. Abbott A (2003) Cell culture: biology's new dimension. Nature 424: 870-872. doi:10.1038/424870a.
10. Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS (2000) Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 19: 4319-4327. doi:10.1038/sj.onc.1203782.
11. Friedrich J, Ebner R, Kunz-Schughart LA (2007) Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int J Radiat Biol 83: 849-871. doi:10.1080/09553000701727531. (Pubitemid 350219104)
12. Kerbel RS, St Croix B, Florenes VA, Rak J (1996) Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum Cell 9: 257-264.
13. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54. doi:10.1038/35094059. (Pubitemid 33741880)
14. Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi J-P, et al. (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 5: e10431. doi:10.1371/journal.pone.0010431.
15. Weigelt B, Lo AT, Park CC, Gray JW, Bissell MJ (2010) HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat 122: 35-43. doi:10.1007/s10549-009-0502-2.
16. Chen L, Xiao Z, Meng Y, Zhao Y, Han J, et al. (2012) The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 33: 1437-1444. doi:10.1016/j.biomaterials.2011.10.056.
17. Hess MW, Pfaller K, Ebner HL, Beer B, Hekl D, et al. (2010) 3D versus 2D cell culture implications for electron microscopy. Methods Cell Biol 96: 649-670. doi:10.1016/S0091-679X(10)96027-5.
18. Botchkina GI, Zuniga ES, Das M, Wang Y, Wang H, et al. (2010) New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Molecular Cancer 9: 192. doi:10.1186/1476-4598-9-192.
19. Ivascu A, Kubbies M (2006) Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis. Journal of Biomolecular Screening 11: 922-932. doi:10.1177/1087057106292763. (Pubitemid 44847146)
20. Keller GM (1995) In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7: 862-869.
21. Kelm JM, Fussenegger M (2004) Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 22: 195-202. doi:10.1016/j.tib-tech.2004.02.002. (Pubitemid 38368179)
22. Wobus AM, Wallukat G, Hescheler J (1991) Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48: 173-182.
23. Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839-845. doi:10.1038/nrm2236. (Pubitemid 47462131)
24. Drewitz M, Helbling M, Fried N, Bieri M, Moritz W, et al. (2011) Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnology Journal 6: 1488-1496. doi:10.1002/biot. 201100290.
25. Khaitan D, Chandna S, Arya MB, Dwarakanath BS (2006) Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 4: 12. doi:10.1186/1479-5876-4-12.
26. Byrne HM (2010) Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 10: 221-230. doi:10.1038/nrc2808.
27. Folkman J, Hochberg M (1973) Self-regulation of growth in three dimensions. J Exp Med 138: 745-753.
28. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, et al. (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Science 101: 293-299. doi:10.1111/j.1349-7006.2009.01419.x.
29. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322. doi:10.1002/(SICI)1097-4652(200003)182: 3〈311::AID-JCP1〉3.0.CO;2-9. (Pubitemid 30054364)
30. Seemayer CA, Kuchen S, Kuenzler P, Rihosková V, Rethage J, et al. (2003) Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 162: 1549-1557. doi:10.1016/S0002-9440(10)64289-7. (Pubitemid 36512838)
31. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, et al. (2010) Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956. doi:10.1158/0008-5472.CAN-10-0785.
32. Räsänen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Experimental Cell Research 316: 2713-2722. doi:10.1016/j.yexcr.2010.04. 032.
33. Dudás J, Fullár A, Bitsche M, Schartinger V, Kovalszky I, et al. (2011) Tumor-produced, active interleukin-1b regulates gene expression in carcinoma-associated fibroblasts. Exp Cell Res 317: 2222-2229. doi:10.1016/j.yexcr.2011.05.023.